Exploitation of HIV protease inhibitor Indinavir as a memory restorative agent in experimental dementia

Pharmacology Biochemistry and Behavior

Volumn 89, Issue 4, 2008, Pages 535-545

  Sharma, Bhupesh ^a   Singh, Nirmal ^a   Singh, Manjeet ^a   Jaggi, Amteshwar Singh ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

Beta amyloid; Dementia; Donepezil; Indinavir; Oxidative stress

Indexed keywords

ACETYLCHOLINESTERASE; BRAIN ENZYME; CELECOXIB; DONEPEZIL; GLUTATHIONE; INDINAVIR; PROTEINASE INHIBITOR; STREPTOZOCIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ALZHEIMER DISEASE; AMNESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DRUG EFFECT; DRUG MEGADOSE; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; LEARNING DISORDER; LOW DRUG DOSE; MALE; MAZE TEST; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SWISS WEBSTER MOUSE;

ACETYLCHOLINESTERASE; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BRAIN; CYCLOOXYGENASE INHIBITORS; DEMENTIA; FEMALE; GLUTATHIONE; HIV PROTEASE INHIBITORS; INDANS; INDINAVIR; MALE; MAZE LEARNING; MEMORY; MEMORY DISORDERS; MICE; NOOTROPIC AGENTS; OXIDATIVE STRESS; PIPERIDINES; PYRAZOLES; STREPTOZOCIN; SULFONAMIDES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

ANIMALIA; MUS;

EID: 41949102996     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.02.012     Document Type: Article

References (43)

1. Abramov A.Y., Canevari L., and Duchen M.R. Beta amyloid peptides induce mitochondrial dysfunction & oxidative stressing astrocytes & death of neurons through activation of NADPH oxidase. J Neurosci 24 (2004) 565-575
2. Beutler E., Duron O., and Kelly B. Reduced glutathione estimation. J Lab Clinical Med 61 (1963) 82
3. Braak H., Del Tredici K., Schultz C., and Braak E. Vulnerability of select neuronal types to Alzheimer's disease. Ann N Y Acad Sci 924 (2000) 53-61
4. Chan C., Dharmarajan A., Atwood C., Huang X., Tanzi R., and Bush A. Anti-apoptotic action of Alzheimer beta amyloid. Alzheimer's Rep 2 (1999) 113-119
5. Choi S.H., Park C.H., Koo J.W., Seo J.H., Kim H.S., Jeong S.J., et al. Memory impairment and cholinergic dysfunction by centrally administered A beta and carboxyl- terminal fragment of Alzheimer's APP in Mice. FASEB J 15 (2001) 1816-1818
6. Dhingra D., Parle M., and Kulkarni S.K. Effect of combination of insulin with dextrose, d (-) fructose and diet on learning and memory in mice. Indian J Pharmacol 35 (2003) 151-156
7. Ellman G.L., Courtney D.K., Andres V., and Feathstone R.M. A new and rapid colorimeteric determination of acetylcholinesterase activity. Biochem Pharmacol 7 (1961) 88-95
8. + channels. Science 264 (1994) 276-279
9. Feillet-Coudray C., Rock E., Coudray C., Grzelkowska K., Azais-Braesco V., Dardevet D., et al. Lipid peroxidation and antioxidant status in experimental diabetes. Clin Chim Acta 284 (1999) 31-43
10. Haley T.J., and McCormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mice. Br J Pharmacol 12 (1957) 12-15
11. Hong L., Koelsch G., Lin X., Wu S., Terzyan S., Ghosh A.K., et al. Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor. Science 290 (2000) 150-153
12. Howlett D.R., Simmons L., Dingwall C., and Christie G. In search of an enzyme: the b-secretase of Alzheimer's disese is an aspartic proteinase. Brain Res Rev 23 (2000) 565-570
13. Hoyer S. The aging brain. Changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late onset sporadic Alzheimer's disease (SAD). A mini review. J Neural Transm 109 (2000) 991-1002
14. Hoyer S. The brain insulin signal transduction system and sporadic (type II) Alzheimer' s disease: an update. J Neural Transm 109 Suppl (2000) 341-360
15. Hoyer S., Muller D., and Plaschke K. Desensitization of brain insulin receptor. Effect on glucose/energy and related metabolism. J Neural Transm 44 Suppl (1994) 259-268
16. Itoh J., Nabeshima T., and Kameyama T. Utility of an elevated plus maze for the evolution of memory in mice. Effects of nootropics, scopolamine and electro convulsive shock. Psychopharmacology 101 (1990) 27-32
17. Jarret J.T., Berger E.P., and Lansbury Jr. P.T. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implication for the pathogenesis of Alzheimer's disease. Biochemistry 32 (1993) 4693-4697
18. Kawas C., Gray S., Brookmeyer R., Fozard J., and Zonderman A. Age-specific incidence rates of Alzheimer's disease: the Baltimore longitudinal study of aging. Neurology 54 (2000) 2072-2077
19. Kim J., Onstead L., Randle S., Price R., Smithson L., Zwizinski C., et al. Aβ40 inhibits amyloid deposition in vivo. J. Neurosci. 27 3 (2007) 627-633
20. Klein W.I., Krafft G.A., and Finch C.E. Targeting small Ab oligomers: the solution to an Alzheimer's disease conundrum. Neurosci 24 (2001) 219-224
21. Kukar T., Murphy M.P., Eriksen J.L., Sagi S.A., Weggen S., and Smith T.E. Diverse compounds mimic Alzheimer's disease-causing mutations by augmenting Aβ42 production. Nature 11 (2005) 545-550
22. Lannert H., and Hoyer S. Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci 112 (1998) 1199-1208
23. Lowry O.H., Rosebrough N.J., Far A.L., and Randall R.J. Protein measurement with folin-phenol reagent. J Biol Chem 193 (1951) 265-275
24. Mayer G., Nitsch R., and Hoyer S. Effects of changes in peripheral and cerebral glucose metabolism on locomotor activity, learning and memory in adult male rats. Brain Res 532 (1990) 95-100
25. Morris R.G.M. Developments of a water maze producer for studying spatial learning in the rats. J Neurosci Meth 11 (1984) 47-60
26. Nunan J., and Small D.H. Regulation of APP cleavage by alpha-, beta- and gamma-secretases. FEBS Lett 483 (2000) 6-10
27. Ohokawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochemistry 95 (1979) 351-358
28. Packard M.G., Teather L.A., and Bazan N.G. Effect of intra-striated injections of platelet-activating factor and PAF antagonist BN 52021 on memory. Neurobiol. Learn. Mem 66 (1996) 176-182
29. Parle M., and Singh N. Animal models for testing memory. Asia Pacific J Pharmacol 16 (2004) 101-120
30. Parle M., and Singh N. Reversal of memory deficits by atorvastatin and simvastatin in rats. YakuGaku Zasshi 127 7 (2007) 1125-1137
31. Reagan L.P., Magarinos A.M., Yee D.K., Swzeda L.I., Van Bueren A., McCall A.L., et al. Oxidative stress and HNE conjugation of GLUT3 are increased in the hippocampus of diabetic rats subjected to stress. Brain Res 862 (2000) 292-300
32. Sakurada T., Sakurada S., Katsuyama S., Sakurada C., No K.T., and Terenius L. Noceceptin (1-7) antagonizes noceceptin induced hyperalgesia in mice. Br. J f Pharmacology 128 (1999) 941-944
33. Selkoe D.J. Alzheimer disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimers Dis 3 (2001) 75-80
34. Sharma M., and Gupta Y.K. Effect of chronic treatment of melatonin on learning, memory and oxidative deficiencies induced by intracerebroventricular streptozotocin in rats. Pharmacol Biochem Behav 70 (2001) 325-331
35. Sharma, B., Singh, N., Singh M. Modulation of celecoxib and streptozotocin induced experimental dementia of Alzheimer's disease type by pitavastatin and donepezil. J Psy Pharmacol (accepted for publication and in press).
36. Shoham S., Bejar C., Kovalev E., and Weinstock M. Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats. Exp Neurol 184 (2003) 1043-1052
37. Smith K.J., Kapoor R., and Felts P.A. Demyelination: the role of reactive oxygen and nitrogen species. Brain Patho 9 (1999) 69-92
38. Song D.K., Won M.H., Jung J.S., Lee J.C., Kang T.C., Suh H.W., et al. Behavioural and neuropathological changes induced by central injection of carboxyl-terminal fragment of beta-amyloid precursor protein in mice. J Neurochem 71 (1998) 875-878
39. Sturchler P.C., Aramowski D., Duke M., Wieder H.K.M., Mistl C., Rothacher C., et al. Two amyloid precursor protein transgenic mouse models with Alzheimer's disease like pathology. Proc Natl Acad. Sci. U.S.A. 9 (1997) 13287-13292
40. Suh G.H., and Kim S.K. Behavioral and Psychological Signs and Symptoms of Dementia (BPSD) in antipsychotic-naive Alzheimer's disease patients. Int Psychogeriatr 16 (2004) 337-350
41. Torre D.L.J., Aliev G., and Perry G. Drug therapy in Alzheimer's disease. Engl J Med 351 (2004) 1911-1913
42. Vas C.J., Pinto C., Panikker D., Noronha S., Deshpande N., Kulkarni L., et al. Prevalence of dementia in an urban Indian population. Int. Psychogeriatr. 13 (2001) 439-450
43. Voss G., and Sachsse K. Red cell and plasma cholinesterase activities in microsamples of human and animal blood determined simultaneously by a modified acetylcholine/DTNB procedure. Toxicol Appl Pharmacol 16 (1970) 764-772